BRPI0818902A2 - Ciclopentanos substituídos tendo atividade de prostaglandina - Google Patents

Ciclopentanos substituídos tendo atividade de prostaglandina

Info

Publication number
BRPI0818902A2
BRPI0818902A2 BRPI0818902A BRPI0818902A2 BR PI0818902 A2 BRPI0818902 A2 BR PI0818902A2 BR PI0818902 A BRPI0818902 A BR PI0818902A BR PI0818902 A2 BRPI0818902 A2 BR PI0818902A2
Authority
BR
Brazil
Prior art keywords
substituted cyclopentanes
prostaglandin activity
prostaglandin
activity
cyclopentanes
Prior art date
Application number
Other languages
English (en)
Inventor
Yariv Donde
Jeremiah H Nguyen
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818902(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0818902A2 publication Critical patent/BRPI0818902A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
BRPI0818902 2007-11-09 2008-11-05 Ciclopentanos substituídos tendo atividade de prostaglandina BRPI0818902A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98684907P 2007-11-09 2007-11-09
PCT/US2008/082469 WO2009061811A1 (en) 2007-11-09 2008-11-05 Substituted cyclopentanes having prostaglanding activity
US12/265,062 US9006464B2 (en) 2007-11-09 2008-11-05 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
BRPI0818902A2 true BRPI0818902A2 (pt) 2015-05-12

Family

ID=40524829

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818902 BRPI0818902A2 (pt) 2007-11-09 2008-11-05 Ciclopentanos substituídos tendo atividade de prostaglandina

Country Status (21)

Country Link
US (1) US9006464B2 (pt)
EP (1) EP2217581B1 (pt)
JP (1) JP2011503089A (pt)
KR (1) KR20100101097A (pt)
CN (2) CN101952261B (pt)
AR (1) AR069228A1 (pt)
AU (1) AU2008324793B2 (pt)
BR (1) BRPI0818902A2 (pt)
CA (1) CA2705150C (pt)
CL (1) CL2008003332A1 (pt)
CO (1) CO6280480A2 (pt)
DK (1) DK2217581T3 (pt)
ES (1) ES2432058T3 (pt)
IL (1) IL205604A (pt)
MX (1) MX2010005105A (pt)
NZ (1) NZ585517A (pt)
RU (1) RU2481339C2 (pt)
TW (1) TWI411438B (pt)
UA (1) UA99840C2 (pt)
WO (1) WO2009061811A1 (pt)
ZA (1) ZA201003304B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
EP3991734A4 (en) 2019-06-28 2023-03-01 Gurus BioPharm Inc. AGENT FOR ENHANCING HAIR GROWTH

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012A (en) * 1850-01-15 Improvement in mowing-machines
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
JPS5623984B2 (pt) * 1973-04-19 1981-06-03
US4065472A (en) * 1975-09-29 1977-12-27 Pfizer Inc. 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
GB1563201A (en) * 1975-11-05 1980-03-19 Shell Int Research Preparation of herbicidally acitve alanine derivatives
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6545045B1 (en) * 1998-12-24 2003-04-08 Alcon Manufacturing, Ltd. Prostaglandin E agonists for treatment of glaucoma
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7585895B2 (en) * 2005-12-06 2009-09-08 Allergan, Inc. Therapeutic substituted cyclopentanes
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
US7960431B2 (en) 2007-02-01 2011-06-14 Allergan, Inc. Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension

Also Published As

Publication number Publication date
JP2011503089A (ja) 2011-01-27
CN102977048A (zh) 2013-03-20
CL2008003332A1 (es) 2011-08-12
RU2010122681A (ru) 2011-12-20
ES2432058T3 (es) 2013-11-29
TW200934500A (en) 2009-08-16
EP2217581A1 (en) 2010-08-18
US20090124676A1 (en) 2009-05-14
EP2217581B1 (en) 2013-07-31
MX2010005105A (es) 2010-05-27
AR069228A1 (es) 2010-01-06
AU2008324793A1 (en) 2009-05-14
DK2217581T3 (da) 2013-10-21
RU2481339C2 (ru) 2013-05-10
CN101952261A (zh) 2011-01-19
KR20100101097A (ko) 2010-09-16
CA2705150A1 (en) 2009-05-14
UA99840C2 (ru) 2012-10-10
AU2008324793B2 (en) 2013-12-05
WO2009061811A8 (en) 2009-07-02
IL205604A (en) 2014-06-30
IL205604A0 (en) 2010-11-30
ZA201003304B (en) 2014-03-26
CO6280480A2 (es) 2011-05-20
NZ585517A (en) 2012-08-31
CN101952261B (zh) 2013-06-12
CA2705150C (en) 2016-06-14
WO2009061811A1 (en) 2009-05-14
TWI411438B (zh) 2013-10-11
US9006464B2 (en) 2015-04-14

Similar Documents

Publication Publication Date Title
CR10851A (es) Inhibidores de la actividad de la akt
BRPI0810191A2 (pt) Escova de dentes
BRPI0821759A2 (pt) Ativador de catalisador contínuo
BRPI0821766A2 (pt) Catalisador de ativação rápida
BRPI0815246A2 (pt) Composição de catalisador
BRPI0810702A2 (pt) Catalisador
BRPI0821479A2 (pt) Catalisador suportado
BRPI0813245A2 (pt) Escova de dentes.
JP2006340726A5 (ja) 再生
JP2006340727A5 (ja) 再生
BRPI0810559A2 (pt) Macadores de doenças
DK2211626T3 (da) Bagværk
DE602008005054D1 (de) Ultraschallsystem
BRPI0818902A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
FI20086154A0 (fi) Katalyyttirakenne
BRPI0910931A2 (pt) ciclopentanos substituídos terapêuticos
CR10745A (es) Analogos de pirazol
BRPI0819707A2 (pt) Ciclopentanos substituídas tendo atividade de prostaglandina
BRPI0907913A2 (pt) Ciclopentanos substituídos tendo atividade de prostaglandina
DE112007003148A5 (de) Belohnungssystem
FI20075912A0 (fi) Katalysaattori
UA15544S (uk) Печиво
UA15700S (uk) Печиво
UA16560S (uk) Печиво
FI7347U1 (fi) Joustolattia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.